Short description
BioShin is a clinical stage biopharmaceutical company.
Description
BioShin is a wholly owned subsidiary of Biohaven Pharmaceuticals, a public biotech company. BioShin is a clinical stage biopharmaceutical company focused on developing medicines. It has proven leadership from global industry and academic settings and a portfolio of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders.
Last funding
Cannot Access
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Shanghai, Shanghai, China, Asia
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Noaccessforu, Absolutely Noaccess, Nopepepe, Cannot Access, Noaccess
Sign in for full access
Founders
Karl Lintel